This page includes the latest FDA filings for Loretta Momme. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| Registration Number | 3005181013 |
| FEI Number | 3005181013 |
| Name | Loretta Momme |
| Owner & Operator | Takara Biotechnology (Dalian) Co., Ltd. |
| Contact Address | 19-No. 2 Dongbei Street Development Zone Dalian CN-21 Liaoning 116600 CN |
| Official Correspondent |
|
| US Agent |
|
| Registration Status | 1 |
| Initial Importer | N |
| Registration Expiration | 2020-04-25 |
| Registration Address | 1290 TERRA BELLA AVE Mountain View, CA 94043 US |
| Establishment Type | Manufacture Medical Device |
Device Company | Device | Date |
|---|---|---|
Loretta Momme [Takara Biotechnology (Dalian) Co., Ltd.] | Titanium Taq SP DNA Polymerase | 2015-04-29 |
Loretta Momme [Takara Biotechnology (Dalian) Co., Ltd.] | Recombinant RNase Inhibitor, GPR | 2015-04-29 |
Loretta Momme [Takara Biotechnology (Dalian) Co., Ltd.] | PrimeSTAR GXL SP Polymerase | 2015-04-29 |
Loretta Momme [Takara Biotechnology (Dalian) Co., Ltd.] | MMLV Reverse Transcriptase, GPR (8000 Units) | 2015-04-29 |
Loretta Momme [Takara Biotechnology (Dalian) Co., Ltd.] | MMLV Reverse Transcriptase, GPR (2000 Units) | 2015-04-29 |
Loretta Momme [Takara Biotechnology (Dalian) Co., Ltd.] | MMLV Reverse Transcriptase, GPR (20,000 Units) | 2015-04-29 |